We are live on ! Find out more
ENTXW

Entera Bio Ltd. Warrant
ENTXW

Delisted

ENTXW was delisted on the 27th of June, 2023.

Back to rankings

2 hedge funds and large institutions have $7K invested in Entera Bio Ltd. Warrant in 2019 Q3 according to their latest regulatory filings, with funds opening new positions, 2 increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

17% more capital invested

Capital invested by funds: $6K → $7K (+$1K)

0% more funds holding

Funds holding: 2 → 2 (0)

Holders
2
Holders Change
–
Holders Change %
0%
% of All Funds
0.04%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
2
Reduced
–
Closed
–
Calls
$162K
Puts
–
Net Calls
+$162K
Net Calls Change
+$33K

Top Buyers

Rank Fund Capital Flow
1
WVP
Worth Venture Partners
New Jersey
+$372
2
UBS Group
UBS Group
Switzerland
+$1

Top Sellers

No sellers this quarter

ENTXW Hedge Fund Activity: Q3 2019 in Review

2 of the 4,574 institutional investors tracked by Wall St. Rank reported a position in Entera Bio Ltd. Warrant (ENTXW) for Q3 2019, worth a combined $7K — up 17% from $6K a quarter earlier.

Fund positioning in ENTXW was balanced in Q3 2019: 0 funds opened new positions, 0 closed out, 2 added to existing stakes and 0 trimmed.

The largest buyer was Worth Venture Partners, adding an estimated $372.

  • 2 institutional investors held Entera Bio Ltd. Warrant (ENTXW) as of Q3 2019, unchanged from Q2 2019.
  • Funds reported $7K of Entera Bio Ltd. Warrant stock for Q3 2019, up 17% quarter-over-quarter.
  • 0 funds opened new Entera Bio Ltd. Warrant positions in Q3 2019 and 0 closed out.
  • The largest Entera Bio Ltd. Warrant buyer in Q3 2019 was Worth Venture Partners, an estimated $372 added.

Based on aggregated 13F filings for Q3 2019.